Ligand validation:5B34

D12: DODECANE

D12 is a Ligand Of Interest in 5B34 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5B34_D12_A_316	3%	72%	0.333	0.688	0.27	0.79	-	1	0	0	100%	1
5B34_D12_A_317	3%	83%	0.343	0.691	0.32	0.46	-	-	0	0	100%	1
5B34_D12_A_315	2%	81%	0.257	0.563	0.37	0.45	-	-	0	0	100%	1
5B34_D12_A_306	1%	85%	0.271	0.438	0.46	0.29	-	-	1	0	100%	1
3UTY_D12_A_501	99%	67%	0.058	0.988	0.22	1.03	-	1	0	0	100%	1
3UTX_D12_B_401	94%	12%	0.076	0.977	1.73	2.32	2	5	0	0	100%	1
4Y9H_D12_A_305	70%	83%	0.094	0.909	0.26	0.52	-	-	0	0	100%	1
3HAS_D12_A_401	69%	0%	0.096	0.91	3.48	6.45	6	5	0	0	100%	1
3HAP_D12_A_403	41%	0%	0.12	0.834	3.27	6.35	6	4	0	0	100%	1
4DX5_D12_A_1111	49%	59%	0.128	0.875	0.44	1.11	-	-	8	0	100%	1
5MZQ_D12_C_401	43%	71%	0.186	0.908	0.33	0.78	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.